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Summary
Objective: To identify functional interleukin-4 (IL4) receptor (IL4R) subtypes and associated Janus kinase/signal transducers and activators of
transcription (JAK/STAT) molecules in human articular chondrocytes and assess the role of JAK/STAT proteins in chondrocyte
mechanotransduction.
Methods: Expression of IL4R subunits and associated molecules was assessed by immunohistochemistry and western blotting. Functional
IL4R were identiﬁed by chemical crosslinking of IL4-stimulated chondrocytes and western blotting. JAK and STAT phosphorylation was as-
sessed by western blotting.
Results: Chondrocytes from normal and osteoarthritic (OA) cartilage express IL4Ra, gc and IL13Ra1 subunits (components of the Type I and
Type II IL4R). In the presence of IL4 only functional Type II IL4Rs were identiﬁed in normal or OA chondrocytes. With the exception of STAT2,
no differences in JAK/STAT expression were detected between normal and OA cartilage. STAT2 was expressed in OA but not normal chon-
drocytes. Mechanical stimulation (MS) resulted in an IL4R-dependent increase in phosphorylated Tyk2 in normal chondrocytes, which could
be abolished by IL1b preincubation. No phosphorylation of STAT5 or STAT6 was detected in either normal or OA chondrocytes following me-
chanical stimulation (MS) IL4 stimulation resulted in a decrease in Tyk2 phosphorylation and an increase in phosphorylation of STAT6 in both
normal and OA chondrocytes.
Conclusion: Chondrocytes from normal and OA cartilage signal through a Type II IL4R. This signalling is via a STAT6-independent pathway.
Differences in IL4 signalling are likely due to crosstalk between integrin and cytokine signalling pathways, and not differences in IL4R
expression.
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Cartilage
Repair
SocietyIntroduction
Under normal physiological activity articular cartilage is sub-
jected to repetitive mechanical forces. These forces play
a crucial role in maintaining the integrity of cartilage1; immo-
bilisation results in matrix breakdown2 whilst abnormal or
excessive loading concentrated in speciﬁc regions of artic-
ular cartilage as a result of joint deformity lead to tissue
remodelling3. Osteoarthritis (OA) is a degenerative disease
of diarthrodial joints characterised by changes in matrix
composition, chondrocyte clustering, cartilage ﬁssuring
and ﬂaking, with eventual exposure of the subchondral
bone. It is thought that these pathological changes may
occur as a result of normal forces acting on structurally
abnormal cartilage or abnormal forces on normal cartilage.
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Received 16 June 2005; revision accepted 20 March 2006.9Mechanical stimulation (MS) of articular cartilage ex-
plants and chondrocytes in culture initiates a number of bio-
chemical and physiological responses including altered
proteoglycan synthesis4 and induction of aggrecan gene
expression5. We have previously shown that MS of chon-
drocytes isolated from normal cartilage results in an upregu-
lation of aggrecan mRNA and a decrease in matrix
metalloproteinase-3 (MMP3) mRNA, a consequence of
which would be a net increase in matrix production6. This
anabolic response is mediated via integrins and interleu-
kin-4 (IL4), which acts in an autocrine/paracrine manner fol-
lowing its release from the cell7. Chondrocytes isolated from
OA cartilage show an altered response to the same me-
chanical stimulus; whilst still recognising the mechanical
stimulus via a5b1 integrins, there is an absence of the ana-
bolic response and IL1b in addition to IL4 is released from
the cell8.
IL4 is a pleiotropic cytokine involved in a wide variety of
cellular responses such as priming and proliferation of T
cells and cell adhesion9,10. In addition to the involvement
of IL4 in the anabolic response of chondrocytes from normal
articular cartilage6, IL4 has been shown to be chondropro-
tective in cartilage biology and play a central role in the
maintenance of the extracellular matrix11e13.
IL4 exerts its biological actions by binding to a heterodi-
meric receptor complex, the IL4 receptor (IL4R), present91
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identiﬁed; the Type I IL4R consists of IL4Ra and common
gamma (gc) subunits whilst the Type II IL4R is composed of
IL4Ra and IL13Ra1 subunits14. Binding of IL4 to IL4Ra sub-
unit leads to receptor dimerisation by recruitment of the sec-
ond receptor subunit and the subsequent activation of the
Janus kinase/signal transducers and activators of transcrip-
tion (JAK/STAT) pathway14,15. The JAKs are cytoplasmic
receptor-associated tyrosine kinases that were ﬁrst impli-
cated in cytokine-stimulated signalling pathways16. To date
four members of the JAK family have been identiﬁed: JAK1,
JAK2, JAK3 and Tyk2. In contrast to JAK1, JAK2 and Tyk2,
which are ubiquitously expressed and can associate with
a number of cytokine receptor subunits, JAK3 has been
shown to be selectively associated with the gc subunit14.
Receptor dimerisation is associated with autophosphory-
lation and transphosphorylation of JAKs17. Activated JAK
proteins further phosphorylate the IL4R, allowing recruit-
ment of SH2 domain-containing STATs, which are subse-
quently phosphorylated by the activated JAKs17. Once
phosphorylated, STATs form homo- or heterodimeric com-
plexes that translocate to the nucleus where they can regu-
late transcription of speciﬁc genes17. STAT6 functions as
a critical mediator of IL4-stimulated gene activation14.
Involvement of JAK/STAT activation in mechanotrans-
duction has been identiﬁed in cell systems such as cardio-
myocytes, where it has been shown that mechanical stretch
induced phosphorylation of JAK/STAT proteins and that this
phosphorylation may be involved in the stretch induced
hypertrophic reponse18,19.
The aimof this present studywas to investigate the expres-
sion of IL4R and associated JAK/STAT signalling molecules
in chondrocytes of normal and OA cartilage and to assess
whether they are involved in the mechanotransduction
pathway of these cells.
Methods and materials
MATERIALS
All reagents were obtained from Sigma (Poole, UK)
unless otherwise stated.
SOURCE OF TISSUE
Human articular cartilage specimens were obtained, with
approval of the local research ethics committee, from
donors at the time of knee joint arthroplasty and limb
resection.
IMMUNOHISTOCHEMISTRY
Representative samples of normal articular cartilage (Col-
lins grade 0) and OA cartilage (Collins grades 1e3)20 were
snap-frozen in liquid nitrogen. Sections, 4 mm in thickness,
were cut with a Bright’s cryostat mounted on superfrost
glass slides, allowed to come to room temperature, and
ﬁxed with acetone for 10 min. Immunohistochemistry was
performed following the Dako Technomate protocol using
the indirect streptavidinebiotin method and a panel of
monoclonal and polyclonal antibodies against IL4Ra, gc,
IL13Ra1 (R&D Systems); JAK1, JAK2, JAK3 (Autogen Bio-
clear UK Ltd); and Tyk2, STAT1, STAT2, STAT3, STAT5
(Transduction Laboratories, Lexington, USA). Negative con-
trols were obtained by using nonspeciﬁc immunoglobulin
instead of the speciﬁc primary antibody.CHONDROCYTE CULTURE
Chondrocytes obtained from human articular cartilage
were isolated by enzymatic release21; samples of normal
and OA cartilage were processed separately. Isolated cells
were seeded at a concentration of 2 105 cells/ml into
58 mm diameter tissue culture dishes (Nunc) containing
Iscove’s modiﬁed Dulbecco’s medium supplemented with
10% foetal calf serum (FCS) 2 mM L-glutamine, 100 IU/ml
penicillin, and 100 mg/ml streptomycin. Primary, non-conﬂu-
ent cultures of human articular chondrocytes from individual
donors were used in each experiment, and each experi-
ment was repeated using cells from a minimum of three
separate donors.
IL4R CROSSLINKING
Chondrocytes were isolated from human articular carti-
lage as previously described and seeded at a density of
2 105cells/ml. Adherent cells were treated with 0.02% eth-
ylenediaminetetraacetic acid (EDTA) (w/v) at 37(C for
5 min and a cell suspension was prepared. Cells were
washed and resuspended at a density of 2 107cells in
0.5 ml of serum-free Iscove’s modiﬁed Dulbecco’s medium
supplemented with 2% bovine serum albumin (BSA). The
cells were incubated with 1 nM IL4 for 1 h at 4(C and
washed twice with Iscove’s medium. Functional IL4R com-
plexes were chemically crosslinked using bis(sulfo-succini-
midyl)suberate (BSSS) (Pierce Endogen, Cheshire, UK)22.
BSSS, dissolved at 40 mM in distilled water, was added
at a ﬁnal concentration of 1 mM to the cell suspension. Fol-
lowing 10 min of incubation at room temperature, a further
aliquot of BSSS was added to the cell suspension and incu-
bated for 20 min. The cells were washed once with Iscove’s
medium and lysed for 30 min on ice in 150 ml buffer contain-
ing 0.5% Igepal, 50 mM Hepes, 150 mM NaCl, 1 mM
MgCl2, 10% glycerol and 100 mM NaF. Cell lysates were
cleared by centrifugation at 13,000 rpm for 30 min at 4(C,
and subjected to SDS-PAGE under non-reducing condi-
tions. Following electrophoresis, proteins were transferred
to polyvinylidene ﬂuoride membranes, blocked and immu-
noblotted as described below, using antibodies to IL4Ra,
gc or IL13Ra1 (R&D Systems).
MECHANICAL STIMULATION
Human articular chondrocytes were mechanically stimu-
lated as previously described21,23,24. Brieﬂy, ﬂexible plastic
tissue culture dishes are placed in a sealed chamber with
inlet and outlet ports. The chamber is pressurised with
helium from a cylinder, the frequency of pressurisation
being dictated by an electronic timer controlling the inlet
and outlet valves. Cyclical pressurisation has been shown
to induce deformation and strain on the base of the plastic
tissue culture dish and its adherent cells21. The standard
regime of cyclical pressurisation used applies 3700 mstrain
at a frequency of 0.33 Hz (2 s on, 1 s off) for 20 min. Following
MS, protein extraction was performed immediately or after
indicated time periods of incubation at 37(C in 95% air/5%
CO2.
EXPERIMENTAL PROTOCOL
To assess the effect of MS on chondrocyte tyrosine
phosphorylation of JAKs and STAT5 or STAT6, dishes
of normal or OA chondrocytes were placed in serum-free
993Osteoarthritis and Cartilage Vol. 14, No. 10Fig. 1. Expression of IL4R subunits and associated signalling molecules in human articular cartilage (40 magniﬁcation). Snap-frozen sec-
tions of human articular cartilage were immunostained with antibodies against the IL4R subunits IL4Ra, IL13Ra1 and gc, and the JAK/
STAT proteins JAKs1-3, Tyk2, STATs1e3 and 5. (a) IL4Ra (OA), (b) gc (normal), (c) IL13Ra1 (normal), (d) JAK2 (normal), (e) Tyk2 (OA),
(f) STAT2 (normal), (g) STAT2 (OA), (h) STAT3 (normal), (i) STAT3 (OA), (j) negative control (normal), and (k) negative control (OA).media overnight, then stimulated for 20 min at 0.33 Hz in
the presence or absence of function blocking antibodies
to the IL4R subunits (10 mg/ml) or neutralising antibodies
to the cytokines IL1b or IL6 (1 mg/ml; R&D Systems).
Following stimulation, proteins were extracted immediately
or dishes were incubated at 37(C for 1 and 2 h in
serum-free media, and then total protein was extracted.
To assess the role of proinﬂammatory cytokines on thechondrocyte tyrosine phosphorylation response to MS,
dishes of normal chondrocytes were preincubated with
recombinant IL1b (10 ng/ml; R&D Systems) for 16 h in
serum-free medium prior to MS as described.
In separate experiments, the effects of IL4 on
chondrocyte tyrosine phosphorylation were examined by
incubation of chondrocytes with recombinant IL4 (10 ng/ml;
R&D Systems) for 20 min, 1 and 2 h without MS.
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Differential expression of IL4R components and JAK proteins in normal and OA articular cartilage (snap-frozen sections of normal and
OA articular cartilage were immunostained with antibodies against IL4Ra, gc, IL13Ra1, JAK1, JAK2, JAK3, Tyk2, STAT1, STAT2, STAT3
and STAT5)
Normal OA
n Superﬁcial Mid/deep n Cluster Mid/deep
IL4Ra 12/12 Negative Positive 28/28 Negative Positive
IL13Ra1 14/14 Negative Positive 13/13 Negative Positive
gc 9/9 Positive Positive 19/19 Positive Positive
JAK1 4/6 Negative Positive 5/6 Negative Positive
JAK2 9/9 Positive Positive 5/6 Positive Positive
JAK3 9/9 Negative Positive 7/7 Negative Positive
Tyk2 5/5 Positive Positive 5/5 Positive Positive
STAT1 10/10 Positive Positive 10/10 Positive Positive
STAT2 18/20 Negative Negative 17/18 Positive Positive
STAT3 22/25 Negative Positive 20/22 Negative Positive
STAT5 10/10 Positive Positive 11/11 Positive PositiveEach experiment was carried out with chondrocytes from
at least three different donors.
PROTEIN EXTRACTION AND WESTERN BLOTTING
Following either MS or cytokine activation, cultured chon-
drocytes were washed with ice-cold phosphate buffered
saline (PBS) containing 100 mM Na3VO4 and lysed with
ice-cold lysis buffer (1% Igepal, 1 mM Na3VO4, and a prote-
ase inhibitor cocktail tablet (Roche Laboratories, Welwyn
Garden City, UK)) for 15 min at 4(C. Cell lysates were
cleared by centrifugation at 13,000 rpm for 15 min. The pro-
tein concentration of cell lysates was determined using the
FolineLowry assay method with a Dynatech MR5000 micro-
plate reader (Dynatech, Alexandria, VA). Equal quantities of
protein from the total cell lysates were electrophoresed on
7.5% sodium dodecyl sulfate (SDS)epolyacrylamide gels
under reducing or non-reducing conditions as dictated
by the protein of interest. Following electrophoresis, theproteins were transferred onto polyvinylidene ﬂuoride mem-
branes and blocked for 1 h at room temperature with TBST
(12.5 mM TriseHCl [pH 7.6], 137 mMNaCl, 0.1% Tween 20)
containing 2% (w/v) BSA. Membranes were incubated over-
night at 4(C with the appropriate antibody diluted in TBST
containing 5% BSA. After washing six times with TBST,
the membranes were incubated for 1 h at room temperature
with the relevant horseradish peroxidase-labelled second-
ary antibody (Dako, Cambridge, UK) diluted in TBST. Mem-
branes were rewashed extensively and protein detection
was performed using the enhanced chemiluminescence
plus western blotting detection system (Amersham, Little
Chalfont, UK), according to the manufacturer’s instructions.
Immunoblots for assessing JAK and STAT phosphoryla-
tion were stripped with a solution containing 62.5 mM Tris
(pH 6.8), 2% SDS, and 100 mM b-mercaptoethanol for
30 min at 55(C before reprobing with antibodies against
total JAK1, JAK2, Tyk2, STAT5 and STAT6 (Autogen
Bioclear UK Ltd, Wilts, UK).IL-4Rα
IL4R complex*
IL-4Rα + IL4 (~155k Da)
250 kDa
160 kDa
* IL-4Rα + IL4  + second chain ~230kDa
** IL-4Rα + IL4 +IL-13Rα1 chain ~ 230kDa
a
250 kDa
Normal OA
IL4R complex**
Normal OA
IL-13Rα1b
Fig. 2. Identiﬁcation of functional IL4Rs in cultured chondrocytes isolated from normal and osteoarthritic cartilage. Cultured chondrocytes iso-
lated from normal (n¼ 3) and OA (n¼ 3) articular cartilage were incubated with recombinant IL4 in the presence of BSSS. Cell lysates from
crosslinked cells were immunoblotted using antibodies against (a) IL4Ra and (b) IL13Ra1 subunits. Crosslinked protein complexes are
marked with arrows.
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PhosphoJAK1, PhosphoJAK2 (Biosource UK Ltd, Bel-
gium), PhosphoTyk2, PhosphoSTAT5, and PhosphoSTAT6
(New England Biolabs Ltd., Hertfordshire, UK) phospho-
speciﬁc antibodies were used.
Receptor antibodies
Receptor antibodies used were IL4Ra, gc and IL13Ra1
(R&D Systems).
IMMUNOPRECIPITATION
Equal amounts of protein were used for immunoprecipita-
tion. For immunoprecipitation of phosphotyrosine, monoclo-
nal anti-phosphotyrosine agarose beads (Sigma) were
incubated with whole cell lysates for 4 h at 4(C. The beads
were sedimented by centrifugation at 13,000 rpm for
15 min, washed twice with ice-cold lysis buffer and once
with ice-cold PBS containing 1 mM Na3VO4. SDS-sample
buffer was added and the beads were boiled for 5 min to
dissociate the proteins. Samples were then assessed for ty-
rosine phosphorylation of JAK3 by immunoblotting with total
JAK3 antibody (Autogen Bioclear UK Ltd) under reducing
conditions.
Results
EXPRESSION OF IL4R IN CHONDROCYTES FROM NORMAL
AND OA CARTILAGE
In vivo expression of IL4R subunits
The IL4R is made up of the IL4R a subunit, and one of
the common gamma chain (gc; Type I receptors) or the
IL13 receptor a1 (Type II receptors). Immunohistochemis-
try was used to investigate the expression of the different
subunits in frozen sections of cartilage. Chondrocytes from
both normal and OA articular cartilage express compo-
nents of both the Type I and Type II IL4Rs (Fig. 1 and
Table I). Positive staining for the gc subunit was found
in chondrocytes in all zones of normal and OA articular
cartilage. In contrast, positive staining for the IL4Ra andIL13Ra1 subunits was only seen in chondrocytes located
within the mid and deep zones of normal and OA articular
cartilage with no staining in chondrocytes located in the
superﬁcial layer of normal cartilage or in the clones of
OA cartilage (Table I).
Identification of functional IL4R expression
in cultured chondrocytes
Having established that chondrocytes from normal and
OA cartilage express components of the Type I (IL4Ra
and gc subunits) and Type II IL4Rs (IL4Ra and
IL13Ra1 subunits) we investigated the presence of func-
tional IL4Rs in cultured chondrocytes. Chondrocytes
from normal and OA cartilage were incubated with re-
combinant IL4, activated IL4Rs were then chemically
crosslinked, and whole cell lysates prepared and western
blot analysis performed using antibodies to the individual
subunits. In the presence of IL4, IL4Ra and IL13Ra1 sub-
units associate to form the functional Type II IL4R (total
molecular weight w225 kDa) in chondrocytes isolated
from both normal and OA articular cartilage [Fig. 2(a,b)].
Figure 2(a) shows a blot probed with antibodies to
IL4Ra, where two bands are visible. The ﬁrst band of ap-
proximately 230 kDa corresponds to the size of IL4Ra,
IL4 and the second subunit complexed together. The sec-
ond band at w150e160 kDa would correspond to IL4
crosslinked to the IL4Ra subunit alone without recruitment
of a second subunit. Figure 2(b) shows a blot probed with
IL13Ra1 antibodies, and has just a single band of ap-
proximately 230 kDa, indicating that the IL4R complex
contains the IL13Ra1 subunit. No association of IL4Ra
and gc subunits could be detected in chondrocytes iso-
lated from either normal or OA articular cartilage, as de-
termined by blotting crosslinked gels with antibodies to
gc (data not shown).
EXPRESSION OF IL4R-ASSOCIATED SIGNALLING MOLECULES
IN CHONDROCYTES FROM NORMAL AND OA CARTILAGE
JAK proteins
Chondrocytes from both normal and OA articular
cartilage express all four members of the Janus kinaseN
OA
MS (mins) 0 10 201 50 10 201 5
P-JAK1 P-JAK2a
N
OA
IL4 (mins)
b
0 20 60 120 0 20 60 120
Fig. 3. Effect of stimulation on JAK phosphorylation. Cultured chondrocytes from normal (n¼ 3) and OA (n¼ 3) cartilage were (a) mechanically
stimulated at 3700 mstrain, at a frequency of 0.33 Hz for up to 20 min or (b) stimulated by the addition of recombinant IL4 for the times indi-
cated. Whole cell lysates were prepared and western blot analysis performed with antibodies against phosphorylated JAK1 or phosphorylated
JAK2.
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Fig. 4. Effect of MS on tyrosine phosphorylation of Tyk2. Cultured chondrocytes from normal cartilage (n¼ 3) were mechanically stimulated at
3700 mstrain, at a frequency of 0.33 Hz for 20 min in the presence or absence of function blocking antibodies to the IL4R subunits. Cultured
chondrocytes from OA cartilage (n¼ 3) were mechanically stimulated in the presence or absence of neutralising antibodies to IL1b, IL4 or IL6.
(a) Whole cell lysates were prepared and western blot analysis performed with antibodies against phosphorylated Tyk2. (b) Densitometry
analysis of western blots for tyrosine phosphorylation of Tyk2 in (i) normal and (ii) OA chondrocytes.familydJAKs 1e3 and Tyk2 (Fig. 1). Expression of
JAK1 and JAK3 was seen in chondrocytes located in
middle and deep zones of both normal and OA carti-
lage, but not in the superﬁcial layer of normal cartilage
or the clusters of cells in OA. Positive staining for JAK2
and Tyk2 was found in chondrocytes in all zones ofboth normal and OA cartilage (Table I). Expression of
JAK proteins in cultured chondrocytes was assessed
by western blotting using total cell extracts of cultured
chondrocytes. Both normal and OA chondrocytes
expressed JAKs1, 2 and 3 and Tyk2 at a similar level
(data not shown).
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Fig. 5. Effect of cytokine incubation on the tyrosine phosphorylation of Tyk2. (a) Cultured chondrocytes from normal cartilage preincubated
with recombinant IL1b (10 ng/ml) for 16 h prior to being mechanically stimulated for 20 min (n¼ 3). Whole cell lysates were prepared and west-
ern blot analysis performed with antibodies against phosphorylated Tyk2. (b) Cultured chondrocytes from normal (n¼ 3) and osteoarthritic
(n¼ 3) cartilage were stimulated by the addition of recombinant IL4 (10 ng/ml) for the indicated periods of time. Whole cell lysates were pre-
pared and western blot analysis performed with antibodies against phosphorylated Tyk2; (i) representative western blot and (ii) densitometry
analysis of western blots.STAT proteins
Chondrocytes in both normal and OA articular cartilage
expressed STATs 1, 3 and 5 (Table I). STAT1 and STAT5
expression was seen in chondrocytes in all zones of normal
and OA cartilage, whilst positive staining for STAT3 was
found only in mid/deep zones of both normal and OA tissue,
not in the superﬁcial zone of normal cartilage or the clones in
OA. Positive staining for STAT2 was found in chondrocytes
in all zones of OA cartilage but not in chondrocytes from nor-
mal cartilage (Fig. 1 and Table I).
No suitable antibodies were identiﬁed for STATs 4 or 6 for
use in immunohistochemistry. Expression of STAT proteins
in cultured chondrocytes was assessed by western blotting
using total cell extracts of cultured chondrocytes. Both normal
and OA chondrocytes expressed STATs 1e3, 5 and 6 ata similar level (data not shown). STAT4 expression was not
assessed.
INVOLVEMENT OF JAK/STAT SIGNALLING IN CHONDROCYTE
RESPONSES TO MECHANICAL AND CYTOKINE STIMULATION
JAK phosphorylation in response to mechanical
or cytokine stimulation
The effect of MS at 0.33 Hz in the presence or absence of
anti-cytokine or anti-IL4R antibodies or following preincuba-
tion with recombinant IL1b, or the addition of recombinant
IL4 on the tyrosine phosphorylation of JAK proteins was as-
sessed by western blotting following immunoprecipitation
by anti-phosphotyrosine (Sigma) or by using phospho-
speciﬁc JAK antibodies (BioSource).
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There is a basal level of tyrosine phosphorylation of JAK1
in unstimulated chondrocytes from both normal and OA car-
tilage. The amount of basal JAK1 phosphorylation varied
between donors. When mechanically stimulated up to
20 min, there was no change in JAK1 phosphorylation in
normal or OA chondrocytes [Fig. 3(a)]. Incubation with IL4
for up to 2 h resulted in variable phosphorylation in both nor-
mal and OA samples, but no consistent changes could be
identiﬁed [Fig. 3(b)].
JAK2
There is a basal level of tyrosine phosphorylation of JAK2
in unstimulated chondrocytes from both normal and OA car-
tilage. Up to and following 20 min MS [Fig. 3(a)] or IL4 incu-
bation for up to 2 h [Fig. 3(b)], there was no consistent
change in JAK2 phosphorylation in either normal or OA
chondrocytes.
JAK3
There was no evidence of tyrosine phosphorylation of
JAK3 in resting (unstimulated) chondrocytes, or following
either MS or the addition of IL4 (data not shown).
Tyk2
There is a variable level of basal tyrosine phosphorylation
of Tyk2 in unstimulated chondrocytes from both normal and
OA cartilage. Following MS for a period of 20 min there was
a small increase in Tyk2 phosphorylation above basal
levels in normal chondrocytes; no change in Tyk2 phos-
phorylation was detected in either normal or OA chondro-
cytes at earlier time points (Fig. 4). This upregulation at
20 min could be inhibited by the presence of antibodies to
IL4Ra or IL13Ra1, but was unaffected by antibodies to gc
(Fig. 4). The presence of antibodies to IL1b, IL4 or IL6
had no effect on the tyrosine phosphorylation of Tyk2 in
OA chondrocytes following MS; no change in tyrosine phos-
phorylation was detected at any time point following MS
(Fig. 4). Preincubation of normal chondrocytes with
recombinant IL1b for 16 h prior to MS decreased basal
levels of Tyk2 phosphorylation and abolished the upregula-
tion of Tyk2 tyrosine phosphorylation following MS
[Fig. 5(a)].
Addition of recombinant IL4 to chondrocyte cultures from
normal cultures resulted in no change at 20 min, but
a decreased phosphorylation of Tyk2 after 1 h exposure
to IL4 [Fig. 5(b)]. No change in Tyk2 phosphorylation
levels could be detected in OA chondrocytes following
incubation with IL4.
Normal OA
P-STAT6
Total STAT6
IL4 (mins) 0 1 5 10 20 60 0 1 5 10 20 60
Fig. 6. Effect of IL4 incubation on the tyrosine phosphorylation of
STAT6 in normal and OA chondrocytes. Cultured chondrocytes
from normal (n¼ 3) and OA (n¼ 3) cartilage were activated by
the addition of recombinant IL4 (10 ng/ml) for the indicated periods
of time. Whole cell lysates were prepared and western blot analysis
performed with antibodies against phosphorylated STAT6.STAT phosphorylation in response to mechanical
or cytokine stimulation
The effect of MS at 0.33 Hz on the tyrosine phosphoryla-
tion of STAT5 and STAT6 was assessed by western blot-
ting using a phospho-speciﬁc antibody. The addition of
recombinant IL4 on STAT6 phosphorylation was also
investigated.
No tyrosine phosphorylation of STAT5 or STAT6 was
detected in chondrocytes from normal or OA cartilage fol-
lowing MS for a period of 20 min (data not shown). How-
ever, an increase in tyrosine phosphorylation of STAT6
was seen in both normal and OA chondrocytes following
the addition of recombinant IL4 for 5 min, which peaked at
10 min in normal chondrocytes and 20 min in OA chondro-
cytes, before declining to baseline levels (Fig. 6).
Discussion
This study has demonstrated that chondrocytes isolated
from normal and OA human articular cartilage express com-
ponents of both the Type I (IL4Ra and gc subunits) and
Type II (IL4Ra and IL13Ra1 subunits) IL4R. We have
also shown that all members of the Janus kinase family
(JAK1e3 and Tyk2) associated with IL4 signalling through
both the Type I and Type II receptor subtypes are
expressed in chondrocytes from both normal and OA human
articular cartilage in vivo and in vitro. However, we have
identiﬁed a difference in STAT expression, with STAT2
expressed in OA, but not normal, cartilage. Interestingly,
STAT2 activation is linked to signalling through interferon-
a25, associated with a therapeutic role in the treatment of ar-
thritis through upregulation of critical cytokine antagonists26,
whilst STAT3 activation has been linked to activation of the
Type II IL4R through involvement of the IL13Ra1 subunit27.
IL4 signalling through the Type I receptor results in dimer-
isation of the IL4Ra and gc subunits and tyrosine phosphor-
ylation of JAK1 or JAK2 (both associated with the IL4Ra
subunit) and JAK3 (associated with the gc subunit)28e30.
Activated JAKs phosphorylate the receptor protein together
with intracellular signalling molecules such as STATs. Once
phosphorylated STATs can dimerise and translocate to the
nucleus, where they regulate gene transcription. IL4R acti-
vation typically leads to activation of STAT6 and insulin re-
ceptor substrate-1 (IRS-1) via JAK131,32, although Type I
IL4R signalling has also been shown to activate STATs 3
and 5 via gc and JAK3 in human B cells33,34. Type II
IL4R mediated signalling involves dimerisation of the
IL4Ra and IL13Ra1 subunits and tyrosine phosphorylation
of Tyk2 (associated with the IL13Ra1 subunit29) instead of
JAK328, leading to activation of STAT6.
Previous work in our laboratory on chondrocyte mechano-
transduction had suggested that there may be differences in
the expression of functional IL4Rs in normal and OA tissue.
In the presence of IL4Ra antibodies, the hyperpolarisation
response in normal chondrocytes following MS was abol-
ished, whilst the presence of gc antibodies had no effect
on this response, suggesting that chondrocytes from normal
articular cartilage utilise the Type II as opposed to the Type I
IL4R subtype6. In contrast, Type I IL4R mediated signalling
in chondrocytes from OA articular cartilage was suggested
as a result of the inhibition of the depolarisation response fol-
lowing MS in the presence of gc antibodies8. Results from
the current study show that there is no difference in the ex-
pression of functional IL4Rs in chondrocytes from normal
and OA articular cartilagedchondrocytes from both normal
999Osteoarthritis and Cartilage Vol. 14, No. 10and OA articular cartilage express a functional Type II IL4R
subtype, although the relative levels of IL4R expression be-
tween normal and OA chondrocytes were not assessed. Fol-
lowing MS of cultured chondrocytes from normal articular
cartilage, there is an increase in phosphorylation of Tyk2
but not JAK3, indicative of signalling through the Type II
and not the Type I IL4R29. These ﬁndings suggest that any
differences in IL4 signalling between normal and OA chon-
drocytes are not due to receptor subunit composition, but
due to activation of downstream signalling pathways or the
presence of soluble receptor antagonists. Evidence is
emerging from genetic studies of a critical role for the
IL4R, with common variants in the IL4Ra gene being linked
to susceptibility to OA35. Whether these variants could affect
intracellular protein associations, and thus intracellular sig-
nal transduction, has yet to be determined.
Although the gc subunit can associate with the IL4Ra
subunit to form the Type I IL4R subtype, this association
is not exclusive, the gc subunit is shared by receptors for
a number of cytokines including IL2, IL7, IL9, IL15 and
IL21 as well as IL433. The participation of the gc subunit
in the depolarisation response suggests that other mem-
bers of the gc-cytokines may be involved in mechanotrans-
duction pathway of chondrocytes isolated from OA articular
cartilage. The ﬁnding that preincubation of normal chondro-
cytes with IL1b inhibits the upregulation of Tyk2 following
MS indicates that IL4 signalling can be modiﬁed by the
presence of other cytokines and not just by variations in
the IL4R subunits. However, the presence of speciﬁc anti-
cytokine antibodies had no effect on the phosphorylation
of Tyk2 in OA chondrocytes following MS, indicating that
it is not the immediate action of IL1b or IL6 during MS
that is modifying the signalling process. This modulation
could be due to the action of other cytokines or catabolic
agents such as NO. Alternatively, this modulation could
be due to the activation of phosphatases such as SHP-1
or SHP-2 by IL1b, which subsequently dephosphorylate
Tyk2. Further studies would be required to establish which
of the possible mechanisms are involved in the mechano-
transduction process in OA, and what role they may have
in modifying the signal transduction pathways.
We could ﬁnd no evidence of tyrosine phosphorylation of
STAT5 or STAT6 following MS of normal or OA chondro-
cytes. This is despite the proteins being present and the
addition of recombinant IL4 resulting in tyrosine phosphory-
lation of STAT6 within 5 min, which clearly indicates that the
chondrocytes have not lost the ability to signal through
STAT6. This suggests that the mechanotransduction path-
ways, although involving release of and autocrine/paracrine
action of IL4, activate a STAT6-independent pathway. Both
STAT3 and STAT5 have been shown to be involved in IL4
signal transduction. STAT5 is involved in IL4 signalling via
the gc receptor subunit33, and STAT3 has been shown to
be activated via the IL13Ra1 subunit of the IL4Rs27. No ev-
idence of any STAT5 phosphorylation could be detected fol-
lowing MS of either normal or OA chondrocytes, which is
consistent with both normal and OA chondrocytes only sig-
nalling through the Type II IL4R. The effect of MS on phos-
phorylation of other STAT proteins was not assessed.
Alternatively, MS of chondrocytes could lead to IL4 signal-
ling via IRS-1 and IRS-2. Both normal and OA chondrocytes
in culture express IRS-1 (data not shown), and IL4 signal
transduction has been shown to involve IRS-1/2ePI3-
kinase-dependent pathways activated via the IL4Ra
subunit14, as well as the JAK/STAT signalling pathways.
In previous studies we have shown that the depolarisation
response of OA chondrocytes to MS can be blocked byPI3-kinase inhibitors8, although they have no effect on the
response of normal chondrocytes to the same mechanical
stimulus. This suggests that OA chondrocytes may well sig-
nal through a PI3-kinase-IRS pathway.
This study, together with our previous ﬁndings, suggest
that, although IL4 associated signalling is involved in the
mechanotransduction pathway in cultured chondrocytes,
there are additional components to the pathway that are,
as yet, unidentiﬁed and modify the signalling of IL4 released
from the cells as a result of MS. These include the action of
other cytokines, such as IL1b, which are known to be in-
volved in the cartilage degradation associated with OA. Fur-
thermore, the differences between the signalling pathways
activated by direct addition of IL4 and MS suggest that there
is regulatory crosstalk between the integrin-activated path-
ways and IL4 signalling. These may be of critical importance
in the modiﬁcation and alteration of mechanotransduction
pathways in diseased tissue. Further work is needed to
follow the sequence of signalling events initiated by MS of
monolayer cultures of chondrocytes from articular cartilage
and to identify the role that other growth factors such as
interferons, Oncostatin-M and IL6 associated with cartilage
biology and JAK/STAT signalling may play26,36,37. Other fac-
tors that may affect the fate of IL4 mediated signalling are
the expression of SOCS proteins, which can themselves
regulate both JAK and STAT activation38. We cannot rule
out the role that IL13 may play in the chondrocyte mechano-
transduction as IL13 is also able to signal through the Type II
IL4R subtype39.
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